EC Number |
Ki Value [mM] |
Ki Value maximum [mM] |
Inhibitor |
Reference |
---|
3.4.21.106 | 0.0000017 |
- |
9-fluorenylmethyloxycarbonyl-NR-ketobenzothiazole |
pH not specified in the publication, temperature not specified in the publication |
754402 |
3.4.21.106 | 0.000003 |
- |
N2-acetyl-N-[1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]-L-leucinamide |
pH not specified in the publication, temperature not specified in the publication |
752986 |
3.4.21.106 | 0.00002 |
- |
PEGylated Kunitz domain-1 |
apparent value |
707989 |
3.4.21.106 | 0.000022 |
- |
N-[1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]-N2-(20-[3,3-dimethyl-5-sulfo-2-[(1E)-3-[(4E)-4-[(2E)-2-(1,3,3-trimethyl-5-sulfo-1,3-dihydro-2H-indol-2-ylidene)ethylidene]cyclohex-1-en-1-yl]prop-1-en-1-yl]-3H-indolium-1-yl]-16-oxo-4,7,10,13-tetraoxa-15-azaicosan-1-oyl)-L-leucinamide |
pH not specified in the publication, temperature not specified in the publication |
752938 |
3.4.21.106 | 0.000022 |
- |
N2-acetyl-N-[5-carbamimidamido-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-L-leucinamide |
pH not specified in the publication, temperature not specified in the publication |
752986 |
3.4.21.106 | 0.0001 |
- |
1-[6-(6-methyl-3H-indol-2-yl)pyridin-2-yl]cyclohexan-1-ol |
pH not specified in the publication, temperature not specified in the publication |
752981 |
3.4.21.106 | 0.00026 |
- |
HAI-2 |
- |
687522 |
3.4.21.106 | 0.001 |
- |
hepatocyte growth factor activator inhibitor-1B |
completely inhibits |
673609 |
3.4.21.106 | 0.001 |
- |
hepatocyte growth factor activator inhibitor-2 |
completely inhibits |
673609 |
3.4.21.106 | 0.0416 |
- |
HI-10331 |
- |
687522 |